tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market
ZNTL
Zentalis Pharmaceuticals
RESEARCH TOOLSreports
Want to see ZNTL full AI Analyst Report?

Zentalis Pharmaceuticals (ZNTL) Income Statement

387 Followers

Zentalis Pharmaceuticals Income Statement

Last quarter (Q4 2025), Zentalis Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zentalis Pharmaceuticals's net income was $-35.22M. See Zentalis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 67.42M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -739.00K$ 67.42M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 145.01M$ 258.62M$ 299.51M$ 227.29M$ 216.54M
Depreciation and Amortization
$ 739.00K$ 1.29M$ 1.39M$ 1.43M$ 544.00K
EBITDA
$ -145.51M$ -186.17M$ -247.60M$ -225.86M$ -207.20M
Operating Income
$ -146.25M$ -191.19M$ -299.51M$ -227.29M$ -216.54M
Other Income/Expenses
$ 9.63M$ 25.50M$ 6.60M$ -10.29M$ 50.15M
Pretax Income
$ -136.62M$ -165.69M$ -292.91M$ -237.58M$ -166.39M
Net Income
$ -137.06M$ -165.84M$ -292.19M$ -236.81M$ -158.72M
Per Share Metrics
Basic EPS
$ -1.91$ -2.33$ -4.47$ -4.48$ -3.72
Diluted EPS
$ -1.91$ -2.33$ -4.47$ -4.48$ -3.72
Weighted Average Shares Outstanding
 71.87M 71.08M 65.41M 52.86M 42.69M
Weighted Average Shares Outstanding (Diluted)
 71.87M 71.08M 65.41M 52.86M 42.69M
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History